VENUS PHARMA GmbH is a hundred percent subsidiary of VENUS Remedies Limited.
In the year 2005, VENUS PHARMA GmbH was born and took over the facilities and staff of former Hefa Frenon AG. This position for VENUS in Germany is a nerve center to conduct business in the EU from a regulatory, logistics and commercial perspective.
We are leveraging our local position in the worlds most regulated and competitive generic market, and building up a strong image and long term business association with a selected set of clients.
Our vision is to be a highly reliable industrial supply partner for the European Generic Injectable Industry.
As VENUS has achieved the critical milestone of EU-GMP certification for its four different formulation sections, VENUS will deliver a dozen different molecules in finished form to the European market.
At present our staff and facilities are highly engaged in meeting the regulatory compliance and developing product control standards in order to bring such a diverse portfolio online.
With this, VENUS aims to be among the top five contract manufacturers for sterile injectable Oncology and top three contract manufacturers for sterile injectable Carbapenems in the world, in terms of technical capability product know how and compliance to European regulation.
We believe that our business and turnovers will continue to develop with the advancement in technical capability and acquisition of clients.
We operate under a business model of contract manufacturing as well as in-house product development out licensing.
VENUS GERMANY is a well established brand for a select group of patented antibiotic combinations and high value generics in territories outside of the EU. Please visit the Exports page for more information
- Core Sales Territory:
Global Regulated Markets
- Formed: 2005